Bioxyne (BXN) Stock Price, News & Analysis

Company Overview

Bioxyne Limited, a life sciences and consumer health products company, manufactures and distributes consumer health products, patented probiotics, health supplements, therapeutic goods, and alternative medicines in the United Kingdom, Japan, Europe, and Australia. The company manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabinoids, cannabis extracts, vitamins, manuka honey, skin care products, and mushroom complexes. It develops various functional food products, such as ingredients; and lactobacillus fermentum VRI-003 for over-the counter gut health immune supplement products. The company also provides product research and development services, and telemedicine services. In addition, it operates BLS Clinics, a telehealth platform. The company provides its products online, as well as through wholesale and direct sales in the United States and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 174,489 shs
• Average Volume: N/A
• Market Capitalization: A$96.31 million
• P/E Ratio: N/A
• Dividend Yield: 2.51%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Consumer Defensive
• Industry: Packaged Foods
• Sub-Industry: N/A
• Current Symbol: ASX:BXN
• CIK: N/A
• Web: www.bioxyne.com
• Phone: 61 2 9078 8180
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$12.80 million
• Net Margins: -142.90%
• Pretax Margin: N/A
• Return on Equity: -409.92%
• Return on Assets: -5.80%

Debt

• Debt-to-Equity Ratio: 18.68
• Current Ratio: 1.92
• Quick Ratio: 2.30

Sales & Book Value

• Annual Sales: A$9.64 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 4.75
• Book Value: A$0.00 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 2,050,000,000
• Free Float: N/A
• Market Cap: A$96.31 million
• Optionable: Not Optionable
• Beta: 0.78